Agilent at AACR 2024

Empowering Breakthroughs in Cancer Research and Diagnostics - Seite 2

Agilent will also host two joint events with key collaborators. The first with SomaLogic, now part of StandardBioTools on Sunday, April 7 at 1:30 pm. The focus of this symposium is cancer understanding and care. Presenters Marc Gunter from Imperial College London and Karl Smith-Byrne from Oxford University will discuss their utilization of SomaLogic’s SomaScan Platform. They will delve into discovering novel causes and biomarkers of cancer within a large-scale prospective cohort.

The second symposium on Sunday, April 7 at 3:30 pm will focus on novel technologies for precision medicine. Caroline Germa, CMO from Transcenta Therapeutics will present on how the use of Claudin 18.2 IHC assay informed Transcenta Therapeutics’ Osemitamab program, and Bellal Moghis from Agilent will discuss Agilent’s new Avida targeted sequencing.

In addition, Agilent will feature partnerships with BostonGene and CiberMed at the Agilent booth (#1531). AACR attendees can also explore multiple Agilent research posters and over 50 additional customer posters highlighting Agilent instruments and solutions. For more details about these events, visit the Agilent booth.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers’ most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, please subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240403009033/en/

The Agilent Technologies Stock at the time of publication of the news with a fall of -0,49 % to 133,2USD on Tradegate stock exchange (03. April 2024, 12:34 Uhr).